Skip to main content
SpringerLink
Log in

Progressive multiple sclerosis and mood disorders

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Mood disorders are very common among multiple sclerosis (MS) patients, but their frequency in patients with progressive course (PMS) has not been adequately researched. Our study aimed to determine the frequency of mood disorders among patients with PMS compared with those with relapsing-remitting MS (RMS) and to explore the associations with disability and disease duration. The study included consecutive outpatients affected by MS according the 2010 revised Mc Donald diagnostic criteria. Psychiatric diagnoses were determined according to DSM-IV by psychiatrists using structured interview tools (ANTAS-SCID). Demographic and clinical data of patients were also collected. Disease courses were defined according to the re-examined phenotype descriptions by the Committee and MS Phenotype Group. Intergroup comparisons were performed by Chi-square test, while logistic regression analysis was performed to assess possible factors associated with mood disorders. In total, 240 MS patients (167 women) were enrolled; of these, 18 % (45/240) had PMS. The lifetime DSM-IV major depression diagnosis (MDD) was established in 40 and 23 % of the PMS and RMS patients, respectively. Using logistic regression analysis, the presence of MDD was independent from disease duration and disability and dependent on PMS course (P = 0.02; OR 2.2). Patients with PMS presented with MDD more frequently than those with RMS, independently from disease duration and physical disability. These findings highlight the importance of considering mood disorders, especially MDD, in the management of PMS patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Compston A, Coles A (2008) Multiple sclerosis. Lancet 372:1502–1517

    Article  CAS  PubMed  Google Scholar 

  2. Zaffaroni M, Ghezzi A (2000) The prognostic value of age, gender, pregnancy and endocrine factors in multiple sclerosis. Neurol Sci 21(4 Suppl 2):S857–S860 (Review)

  3. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG (2000) Multiple sclerosis. N Engl J Med 343(13):938–952 (Review)

  4. Vukusic S, Confavreux C (2007) Natural history of multiple sclerosis: risk factors and prognostic indicators. Curr Opin Neurol 20(3):269–274

    Article  PubMed  Google Scholar 

  5. Lublin FD, Reingold SC (1996) Defining the clinical course of multiple sclerosis: results of an international survey. National multiple sclerosis society (USA) advisory committee on clinical trials of new agents in multiple sclerosis. Neurology 46(4):907–911

    Article  CAS  PubMed  Google Scholar 

  6. Lublin FD, Reingold SC, Cohen JA, Cutter GR, Sørensen PS, Thompson AJ,Wolinsky JS, Balcer LJ, Banwell B, Barkhof F, Bebo B Jr, Calabresi PA, Clanet M, Comi G, Fox RJ, Freedman MS, Goodman AD, Inglese M, Kappos L, Kieseier BC,Lincoln JA, Lubetzki C, Miller AE, Montalban X, O’Connor PW, Petkau J, PozzilliC, Rudick RA, Sormani MP, Stüve O, Waubant E, Polman CH (2014) Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology 83(3):278–286

  7. Ebers GC (2004) Natural history of primary progressive multiple sclerosis. Mult Scler 10(suppl 1):S8–S13

    Article  PubMed  Google Scholar 

  8. Confavreux C, Vukusic S (2006) Natural history of multiple sclerosis: a unifying concept. Brain 129:606–616

    Article  PubMed  Google Scholar 

  9. Rovira A, Swanton J, Tintoré M, Huerga E, Barkhof F, Filippi M, Frederiksen JL, Langkilde A, Miszkiel K, Polman C, Rovaris M, Sastre-Garriga J, Miller D, Montalban X (2009) A single, early magnetic resonance imaging study in the diagnosis of multiple sclerosis. Arch Neurol 66(5):587–592

    Article  PubMed  Google Scholar 

  10. Miller JR (2004) The importance of early diagnosis of multiple sclerosis. J Manag Care Pharm 10(3 Suppl B):S4–S11

  11. Wiendl H, Hohlfeld R (2009) Multiple sclerosis therapeutics: unexpected outcomes clouding undisputed successes. Neurology 72(11):1008–1015

    Article  CAS  PubMed  Google Scholar 

  12. Hauser SL, Chan JR, Oksenberg JR (2013) Multiple sclerosis: prospects and promise. Ann Neurol 74(3):317–327

    Article  CAS  PubMed  Google Scholar 

  13. Benito-León J, Morales JM, Rivera-Navarro J (2002) Health-related quality of life and its relationship to cognitive and emotional functioning in multiple sclerosis patients. Eur J Neurol 9(5):497–502

    Article  PubMed  Google Scholar 

  14. Patti F, Cacopardo M, Palermo F, Ciancio MR, Lopes R, Restivo D, Reggio A (2003) Health-related quality of life and depression in an Italian sample of multiple sclerosis patients. J Neurol Sci 211(1–2):55–62

    Article  PubMed  Google Scholar 

  15. Amato MP, Ponziani G, Rossi F, Liedl CL, Stefanile C, Rossi L (2001) Quality of life in multiple sclerosis: the impact of depression, fatigue and disability. Mult Scler 7(5):340–344

    Article  CAS  PubMed  Google Scholar 

  16. Patten SB, Beck CA, Williams JV, Barbui C, Metz LM (2003) Major depression in multiple sclerosis: a population-based perspective. Neurology 61(11):1524–1527

    Article  CAS  PubMed  Google Scholar 

  17. Sadovnick AD, Remick RA, Allen J, Swartz E, Yee IM, Eisen K, Farquhar R, Hashimoto SA, Hooge J, Kastrukoff LF, Morrison W, Nelson J, Oger J, Paty DW (1996) Depression and multiple sclerosis. Neurology 46(3):628–632

    Article  CAS  PubMed  Google Scholar 

  18. Schiffer RB, Wineman NM, Weitkamp LR (1986) Association between bipolar affective disorder and multiple sclerosis. Am J Psychiatry 143(1):94–95

    Article  CAS  PubMed  Google Scholar 

  19. Feinstein A, O’Connor P, Gray T, Feinstein K (1999) The effects of anxiety on psychiatric morbidity in patients with multiple sclerosis. Mult Scler. 5(5):323–326

    Article  CAS  PubMed  Google Scholar 

  20. Bombardier CH, Blake KD, Ehde DM, Gibbons LE, Moore D, Kraft GH (2004) Alcohol and drug abuse among persons with multiple sclerosis. Mult Scler 10(1):35–40

  21. Carta MG, Moro MF, Lorefice L, Trincas G, Cocco E, Del Giudice E, Fenu G, Colom F, Marrosu MG (2014) The risk of bipolar disorders in multiple sclerosis J Affect Disord 155:255–260

    Article  CAS  PubMed  Google Scholar 

  22. Zabad RK, Patten SB, Metz LM (2005) The association of depression with disease course in multiple sclerosis. Neurology 64(2):359–360

    Article  PubMed  Google Scholar 

  23. Feinstein A, Feinstein K (2001) Depression associated with multiple sclerosis. Looking beyond diagnosis to symptom expression. J Affect Disord 66(2–3):193–198

    Article  CAS  PubMed  Google Scholar 

  24. Carta MG, Moro MF, Lorefice L, Picardi A, Trincas G, Fenu G, Cocco E, Floris F, Bessonov D, Akiskal HS, Marrosu MG (2014) Multiple sclerosis and bipolar disorders: the burden of comorbidity and its consequences on quality of life. Affect Disord 2(167C):192–197

    Article  Google Scholar 

  25. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50(1):121–127

    Article  CAS  PubMed  Google Scholar 

  26. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O’Connor PW, Sandberg-Wollheim M, Thompson AJ, Weinshenker BG, Wolinsky JS (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol 58(6):840–846 (Review)

  27. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O’Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69(2):292–302

    Article  PubMed Central  PubMed  Google Scholar 

  28. Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33(11):1444–1452

    Article  CAS  PubMed  Google Scholar 

  29. Carta MG, Aguglia E, Bocchetta A, Balestrieri M, Caraci F, Casacchia M, Dell’Osso L, DiSciascio G, Drago F, Faravelli C, Lecca ME, Moro MF, Morosini PL, Marcello N, Palumbo G, Hardoy MC (2010) Theuseof antidepressant drugs and the lifetime prevalence of major depressive disorders in Italy. Clin Pract Epidemiol Ment Health 6:94–100

    Article  PubMed Central  PubMed  Google Scholar 

  30. First M, Spitzer R, Gibbon M, Williams J (2002) Structured Clinical Interview for DSM-IV-TR axis I disorders, research version, patient edition with psychotic screen (SCID-I/P W/PSY SCREEN). Biometrics Research, New York State Psychiatric Institute, New York

  31. Rao SM, Cognitive Function Study Group of the National Multiple Sclerosis Society (1991) A manual for the brief repeatable battery of neuropsychological tests in multiple sclerosis. Medical College of Wisconsin, Milwaukee

  32. Muzina DJ, Kemp DE, McIntyre RS (2007) Differentiating bipolar disorders from major depressive disorders: treatment implications. Ann Clin Psychiatry 19(4):305–312

  33. Cocco E, Sardu C, Massa R, Mamusa E, Musu L, Ferrigno P, Melis M, Montomoli C, Ferretti V, Coghe G, Fenu G, Frau J, Lorefice L, Carboni N, Contu P, Marrosu MG (2011) Epidemiology of multiple sclerosis in south-western Sardinia. Mult Scler 17(11):1282–1289

    Article  PubMed  Google Scholar 

  34. Cocco E, Sardu C, Pieroni E, Valentini M, Murru R, Costa G, Tranquilli S, Frau J, Coghe G, Carboni N, Floris M, Contu P, Marrosu MG (2012) HLA-DRB1-DQB1 haplotypes confer susceptibility and resistance to multiple sclerosis in Sardinia. PLoS One 7(4):e33972

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  35. Galeazzi GM, Ferrari S, Giaroli G, Mackinnon A, Merelli E, Motti L, Rigatelli M (2005) Psychiatric disorders and depression in multiple sclerosis outpatients: impact of disability and interferon beta therapy. Neurol Sci 26(4):255–262

    Article  CAS  PubMed  Google Scholar 

  36. McIvor GP, Riklan M, Reznikoff M (1984) Depression as a function of length and severity of illness, age, remission and perceived social support. J Clin Psychol 40:1028–1033

    Article  CAS  PubMed  Google Scholar 

  37. Zorzon M, de Masi R, Nasuelli D, Ukmar M, Pozzi Mucelli R, Cazzato G et al (2001) Depression and anxiety in multiple sclerosis. A clinical and MRI study in 95 subjects. J Neurol 248:416–421

    Article  CAS  PubMed  Google Scholar 

  38. Möller A, Wiedemann G, Rohde U, Backmund H, Sonntag A (1994) Correlates of cognitive impairment and depressive mood disorder in multiple sclerosis. Acta Psychiatr Scand 89(2):117–121

    Article  PubMed  Google Scholar 

  39. Chwastiak L, Ehde DM, Gibbons LE, Sullivan M, Bowen JD, Kraft GH (2002) Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample. Am J Psychiatry 159(11):1862–1868

    Article  PubMed  Google Scholar 

  40. Schubert DS, Burns R, Paras W, Sioson E (1992) Decrease of depression during stroke and amputation rehabilitation. Gen Hosp Psychiatry 14(2):135–141

    Article  CAS  PubMed  Google Scholar 

  41. Schubert DS, Taylor C, Lee S, Mentari A, Tamaklo W (1992) Physical consequences of depression in the stroke patient. Gen Hosp Psychiatry 14(1):69–76

    Article  CAS  PubMed  Google Scholar 

  42. Millefiorini E, Padovani A, Pozzilli C, Loriedo C, Bastianello S, Buttinelli C, Di Piero V, Fieschi C (1992) Depression in the early phase of MS: influence of functional disability, cognitive impairment and brain abnormalities. Acta Neurol Scand 86(4):354–358

    Article  CAS  PubMed  Google Scholar 

  43. Tsivgoulis G, Triantafyllou N, Papageorgiou C, Evangelopoulos ME, Kararizou E, Sfagos C, Vassilopoulos D (2007) Associations of the expanded disability status scale with anxiety and depression in multiple sclerosis outpatients. Acta Neurol Scand 115(1):67–72

    Article  CAS  PubMed  Google Scholar 

  44. Chiaravalloti ND, DeLuca J (2008) Cognitive impairment in multiple sclerosis. Lancet Neurol 7(12):1139–1151

    Article  PubMed  Google Scholar 

  45. Dennison L, Moss-Morris R, Chalder T (2009) A review of psychological correlates of adjustment in patients with multiple sclerosis. Clin Psychol Rev 29(2):141–153

    Article  PubMed  Google Scholar 

  46. Hawker K (2011) Progressive multiple sclerosis: characteristics and management. Neurol Clin 29:423–434

    Article  PubMed  Google Scholar 

  47. Thompson AJ, Toosy AT, Ciccarelli O (2010) Pharmacological management of symptoms in multiple sclerosis: current approaches and future directions. Lancet Neurol 9:1182–1199

  48. Solaro C, Mancardi G (2008) Symptomatic therapies in multiple sclerosis. Introduction. Neurol Sci 29(Suppl 4):S347

    Article  PubMed  Google Scholar 

  49. Miller DM, Allen R (2010) Quality of life in multiple sclerosis: determinants, measurement, and use in clinical practice. Curr Neurol Neurosci Rep 10:397–406

    Article  PubMed  Google Scholar 

  50. Chwastiak L, Ehde DM (2007) Psychiatric issues in multiple sclerosis. Psychiatr Clin North Am 30(4):803–817

    Article  PubMed Central  PubMed  Google Scholar 

  51. Goldman Consensus Group (2005) The Goldman Consensus statement on depression in multiple sclerosis. Mult Scler 11:328–337

    Article  Google Scholar 

  52. Feinstein A, O’Connor P, Feinstein K (2002) Multiple sclerosis, interferon beta 1b and depression. J Neurol 24:815–820

    Article  Google Scholar 

  53. Patten SB, Neutel CI (2000) Corticosteroid-induced adverse psychiatric effects: incidence, diagnosis and management. Drug Saf 22:111–122

    Article  CAS  PubMed  Google Scholar 

  54. Feinstein A, Roy P, Lobaugh N, Feinstein K, O’Connor P, Black S (2004) Structural brain abnormalities in multiple sclerosis patients with major depression. Neurology 62(4):586–590

    Article  CAS  PubMed  Google Scholar 

  55. Bonavita S, Tedeschi G, Gallo A (2013) Morphostructural MRI abnormalities related to neuropsychiatric disorders associated to multiple sclerosis. Mult Scler Int 2013:102454

    PubMed Central  PubMed  Google Scholar 

  56. Goretti B, Portaccio E, Zipoli V, Razzolini L, Amato MP (2010) Coping strategies, cognitive impairment, psychological variables and their relationship with quality of life in multiple sclerosis. Neurol Sci 31(Suppl 2):S227–S230

    Article  PubMed  Google Scholar 

  57. Grassi L, Mangelli L, Fava GA, Grandi S, Ottolini F, Porcelli P, Rafanelli C, Rigatelli M, Sonino N (2007) Psychosomatic characterization of adjustment disorders in the medical setting: some suggestions for DSM-V. J Affect Disord 101(1–3):251–254

    Article  PubMed  Google Scholar 

  58. Brassington JC, Marsh NV (1998) Neuropsychological aspects of multiple sclerosis. Neuropsychol Rev 8(2):43–77

    Article  CAS  PubMed  Google Scholar 

  59. Patten SB (2005) Treatment of neuropsychiatric syndromes in multiple sclerosis. Expert Rev Neurother 5(3):413–420

    Article  PubMed  Google Scholar 

  60. Solaro C, Bergamaschi R, Rezzani C, Mueller M, Trabucco E, Bargiggia V, Dematteis F, Mattioda A, Cimino V, Restivo D, Patti F, Cavalla P (2013) Duloxetine is effective in treating depression in multiple sclerosis patients: an open-label multicenter study. Clin Neuropharmacol 36(4):114–116

  61. Lorefice L, Mura G, Coni G, Fenu G, Sardu C, Frau J, Coghe G, Melis M, Marrosu MG, Cocco E (2013) What do multiple sclerosis patients and their caregivers perceive as unmet needs? BMC Neurol 15(13):177

    Article  Google Scholar 

Download references

Conflict of interest

No conflict of interest exists regarding the present paper.

Author information

Authors and Affiliations

  1. Department of Public Health and Clinical and Molecular Medicine, Multiple Sclerosis Center, University of Cagliari, Cagliari, Italy

    Lorena Lorefice, G. Fenu, J. Frau, G. C. Coghe & E. Cocco

  2. Consultation Liaison Psychiatric Unit at the University Hospital of Cagliari, University of Cagliari and AOU Cagliari, Cagliari, Italy

    G. Trincas, M. F. Moro & M. G. Carta

  3. Department of Medical Sciences, Multiple Sclerosis Center, University of Cagliari, Cagliari, Italy

    M. G. Marrosu

Authors
  1. Lorena Lorefice
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Fenu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Trincas
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. F. Moro
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. Frau
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G. C. Coghe
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. E. Cocco
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. M. G. Marrosu
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. M. G. Carta
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lorena Lorefice.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lorefice, L., Fenu, G., Trincas, G. et al. Progressive multiple sclerosis and mood disorders. Neurol Sci 36, 1625–1631 (2015). https://doi.org/10.1007/s10072-015-2220-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-015-2220-3

Keywords

Search

Navigation